SUVRETTA CAPITAL MANAGEMENT LLC 13D and 13G filings for Biohaven Pharmaceutical Holding Company Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:08 pm Purchase | 2023-12-31 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | SUVRETTA CAPITAL MANAGEMENT LLC | 4,572,836 5.700% | 723,898 (+18.81%) | Filing |
| 2023-02-13 1:31 pm Purchase | 2022-12-31 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | SUVRETTA CAPITAL MANAGEMENT LLC | 3,848,938 5.700% | 8,600 (+0.22%) | Filing |
| 2022-11-02 09:35 am Purchase | 2022-10-21 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | SUVRETTA CAPITAL MANAGEMENT LLC | 3,840,338 5.600% | 3,840,338 (New Position) | Filing |